Matis, S <br/><br/>
PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease.  [electronic resource] 

 -  Cancer gene therapy  Oct 2009 
 - 786-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5500 
<br/><br/><label>Standard No.: </label>10.1038/cgt.2009.26  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Burkitt Lymphoma--drug therapy<br/>Cell Line, Tumor<br/>Cell Transformation, Viral<br/>Female<br/>Humans<br/>Luciferases, Firefly--biosynthesis<br/>Luminescent Measurements<br/>Mice<br/>Mice, SCID<br/>Peptide Nucleic Acids--pharmacology<br/>Proto-Oncogene Proteins c-myc--biosynthesis<br/>Transfection<br/>Xenograft Model Antitumor Assays